MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.

作者: L Xu , S Chen , R C Bergan

DOI: 10.1038/SJ.ONC.1209337

关键词:

摘要: Although cell invasion is a necessary early step in cancer metastasis, its regulation not well understood. We have previously shown, human prostate cancer, that transforming growth factor beta (TGFbeta)-mediated increases are dependent upon activation of the serine/threonine kinase, p38 MAP kinase. In current study, downstream effectors kinase were sought by first screening for proteins phosphorylated after TGFbeta treatment, only absence chemical inhibitors This led us to investigate mitogen-activated protein kinase-activated 2 (MAPKAPK2), known substrate as heat-shock 27 (HSP27), MAPKAPK2, both PC3 and PC3-M cells. After transient transfection, wild-type MAPKAPK2 HSP27 increased TGFbeta-mediated matrix metalloproteinase type (MMP-2) activity, invasion, which turn was inhibited SB203580, an inhibitor Conversely, dominant-negative blocked phosphorylation HSP27, whereas or mutant, non-phosphorylateable, each MMP-2, invasion. Similarly, knock down together, siRNA, also study demonstrates MMP-2 cancer.

参考文章(30)
D. Stokoe, D.G. Campbell, S. Nakielny, H. Hidaka, S.J. Leevers, C. Marshall, P. Cohen, MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. The EMBO Journal. ,vol. 11, pp. 3985- 3994 ,(1992) , 10.1002/J.1460-2075.1992.TB05492.X
Yueqin Liu, Edward Kyle, Ronald Lieberman, James Crowell, Gary Kelloff, Raymond C. Bergan, Focal adhesion kinase (FAK) phosphorylation is not required for genistein-induced FAK-β-1-integrin complex formation Clinical & Experimental Metastasis. ,vol. 18, pp. 203- 212 ,(2000) , 10.1023/A:1006729106034
Eric Krump, Jasbinder S. Sanghera, Steven L. Pelech, Wendy Furuya, Sergio Grinstein, Chemotactic Peptide N-formyl-Met-Leu-Phe Activation of p38 Mitogen-activated Protein Kinase (MAPK) and MAPK-activated Protein Kinase-2 in Human Neutrophils Journal of Biological Chemistry. ,vol. 272, pp. 937- 944 ,(1997) , 10.1074/JBC.272.2.937
Daijiro Hatakeyama, Osamu Kozawa, Masayuki Niwa, Hiroyuki Matsuno, Hidenori Ito, Kanefusa Kato, Norichika Tatematsu, Toshiyuki Shibata, Toshihiko Uematsu, Upregulation by retinoic acid of transforming growth factor-β-stimulated heat shock protein 27 induction in osteoblasts: involvement of mitogen-activated protein kinases Biochimica et Biophysica Acta. ,vol. 1589, pp. 15- 30 ,(2002) , 10.1016/S0167-4889(01)00183-5
Keith P. Wilson, Patricia G. McCaffrey, Kathy Hsiao, Sam Pazhanisamy, Vincent Galullo, Guy W. Bemis, Matthew J. Fitzgibbon, Paul R. Caron, Mark A. Murcko, Michael S.S. Su, The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase Chemistry & Biology. ,vol. 4, pp. 423- 431 ,(1997) , 10.1016/S1074-5521(97)90194-0
Elisa C. Woodhouse, Rodrigo F. Chuaqui, Lance A. Liotta, General mechanisms of metastasis Cancer. ,vol. 80, pp. 1529- 1537 ,(1997) , 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F
L. Attisano, Signal Transduction by the TGF-beta Superfamily Science. ,vol. 296, pp. 1646- 1647 ,(2002) , 10.1126/SCIENCE.1071809
M.B. Sporn, The war on cancer The Lancet. ,vol. 347, pp. 1377- 1381 ,(1996) , 10.1016/S0140-6736(96)91015-6
A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, M. J. Thun, Cancer statistics, 2005. CA: A Cancer Journal for Clinicians. ,vol. 55, pp. 10- 30 ,(2005) , 10.3322/CANJCLIN.55.1.10